Skip to content

Understanding the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTion

Understanding the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTion - RECAST

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025715
Enrollment
210
Registered
2021-09-10
Start date
2020-10-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J06.9 J12.8

Interventions

Group 1: No intervention, observational study. We take samples from children and their household members to elucidate the immune response to SARS-CoV-2.

Sponsors

Charité Universitätsmedizin Berlin, Institut für Immunologie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Infection with SARS-CoV-2 resp. in the control group no infection

Exclusion criteria

Exclusion criteria: pre-existing condition that influences the immune system therapies that influence the immune system

Design outcomes

Primary

MeasureTime frame
Target pf this study is to elucidate with a multi-omics approach, which factors account for the resilience of children compared to adults in an infection with SARS-CoV-2.

Countries

Germany

Contacts

Public ContactSebastian Stricker

Charité – Universitätsmedizin BerlinDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine

recast@charite.de030 450616446

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026